Navigation Links
AstraZeneca Leads Local Walking Movement
Date:9/7/2007

- Wilmington Employees Start! Lacing Up Their Walking Shoes -

WILMINGTON, Del., Sept. 7 /PRNewswire-USNewswire/ -- AstraZeneca continues its fight against sedentary lifestyles by participating in the American Heart Association (AHA)'s Start! movement in Wilmington to promote walking and other healthy habits in the workplace. AstraZeneca employees in their hometown of Wilmington have formed a Start! "walkforce" team to participate in today's Wilmington Start! Heart Walk at Chase Center Riverfront. Start! encourages Americans and their employers to live longer, stronger and healthier lives by engaging in regular physical activity. AstraZeneca is one of three national sponsors of Start! and has been recognized as a leader for supporting innovative corporate wellness initiatives.

"Because heart disease is the nation's number-one killer and a leading cause of death in Delaware, we continue to build on AstraZeneca's strong legacy in cardiovascular treatments by leading this movement to help the Wilmington community get moving," said David Nicoli, AstraZeneca Vice President Corporate Affairs and the company's Wilmington Start! leader. "As a healthcare company dedicated to improving the lives of people globally, the job starts locally with our own employees. We challenge other corporations in our community to join us as part of the Start! movement and make a commitment to wellness."

AstraZeneca is also the national sponsor of the Create Hope Community, part of the Heart Healthy festivities following the Wilmington Start! Heart Walk. The exhibit provides walkers with an interactive and personalized health experience, offers free blood pressure and cholesterol screenings, educational health information, and tools to promote healthier lifestyles.

AstraZeneca encourages employees to incorporate exercise into their workday with lunch time walking programs and access to onsite fitness facilities. At its U.S. headquarters in Wilmington, the compa
'/>"/>

SOURCE AstraZeneca
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Astrazenecas Investigational Cancer Therapies Revealed at ASCO
2. Drinking arsenic water leads to cancer
3. Coronary stent leads to complications
4. Starving leads to obesity
5. Drug abuse leads to long standing changes in the brain
6. Deprived sleep leads to ageing
7. Tobacco chewing leads to dental caries
8. Tongue piercing leads to bacterial infection
9. Cathine leads to mental health disorder
10. Space research leads to needle-free blood tests
11. Canada stunned as mad cow discovery leads to beef ban
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... ... September 04, 2015 , ... Having access to a doctor can sometimes ... increasing amount of unnecessary emergency room visits which affects hospitals’ abilities to provide quality ... bill. Fortunately, a solution to alleviate this problem has recently presented itself, the new ...
(Date:9/4/2015)... DC (PRWEB) , ... September 04, 2015 , ... ... they all pale in comparison to settlements under the Stark physician self-referral law. ... an upcoming Sept. 17 webinar from Atlantic Information Services, Inc. (AIS), will detail ...
(Date:9/4/2015)... ... 2015 , ... Friday night, Chicago lovebirds Jenny McCarthy and Donnie Wahlberg celebrated ... event supporting families affected by autism, raising nearly $250,000. , 150 guests, including ... the Oscar Swan Inn to support the cause. , McCarthy tugged the heartstrings ...
(Date:9/3/2015)... (PRWEB) , ... September 03, 2015 , ... TransPack Toon ... Users can choose from wipes and framing transitions in 30 different styles. Presets ... exclusively for Final Cut Pro X. , TransPack Toon features 90 cartoon transitions from ...
(Date:9/3/2015)... ... September 03, 2015 , ... ... Inc., a leading national healthcare solutions organization, to provide electronic medical record (EMR) ... this agreement, Amerinet members will receive negotiated pricing on E-Volve Health’s Epic EMR ...
Breaking Medicine News(10 mins):Health News:Telemedicine Platform DocChat Announces Launch Offering a Way for Patients to Consult Doctors and Receive Prescriptions 24/7 2Health News:Telemedicine Platform DocChat Announces Launch Offering a Way for Patients to Consult Doctors and Receive Prescriptions 24/7 3Health News:Sept. 17 Webinar to Offer Best Practices for Physician Contracts 2Health News:Jenny McCarthy & Donnie Wahlberg Help Raise Over $200,000 For Generation Rescue’s ‘Night Of Hope’ Chicago Charity Event 2Health News:Pixel Film Studios Releases TransPack Toon, a New FCPX Transition 2Health News:E-Volve Health to Offer EMR Consulting Solutions to Amerinet Members 2
... Shire was the foremost patch medication approved to treat ... of methylphenidate - DAYTRANA, is now available in pharmacies ... 20 mg and 30 mg. ,'The availability of DAYTRANA, ... and parents with a new, practical way to individualize ...
... 2 chromosomes located at 1p and 19q predicted the prognosis ... J. Curran Jr., M.D., professor and chair of radiation oncology ... have found a paradigm shift in managing rare, malignant but ... last week in the Journal of Clinical Oncology, Dr. Curran ...
... The Gay Men’s Health Survey (GMHS) has identified that recently a ... HIV experience unemployment//. ,It also shows that about 50% ... forced to engage in sexual activity against their will. It was ... 20 to 40 were tested positive for HIV. The result ...
... Smith Glaxo Kline has found to be effective in preventing ... viruses (HPVs). ,Researchers suggested that HPV vaccination ... of the subjects. ,In the past 20 years, ... the discovery of the link between HPV and cervical cancer. ...
... dieting have shifted to high-fat and low-carbohydrate level.Researchers at ... of Colorado have noticed from the National Weight Control ... diet have increased over the past decade, while without ... National Weight Control Registry is a national study, tracking ...
... Celiac disease sufferers often endure a life of dietary restrictions, ... eaten foods//, ever passes their lips. ,But this may ... found that an enzyme originally developed for commercial food processing ... in the stomach before it reaches the small intestine. This ...
Cached Medicine News:Health News:Shire Developed DAYTRANA – The First Medication to Treat ADHD Symptom 2Health News:Shire Developed DAYTRANA – The First Medication to Treat ADHD Symptom 3Health News:Shire Developed DAYTRANA – The First Medication to Treat ADHD Symptom 4Health News:Missing Chromosomes Revealed Brain Tumor Therapy Effect – Research Find 2Health News:Missing Chromosomes Revealed Brain Tumor Therapy Effect – Research Find 3Health News:Dieting Behaviors Changed Among Weight Losers 2Health News:Dieting Behaviors Changed Among Weight Losers 3Health News:Celiac Disease Sufferers See an End to their Misery 2
(Date:9/4/2015)... 4, 2015  PTC Therapeutics, Inc. (NASDAQ: ... of its first-ever global awards program, the STRIVE ... designed to aid nonprofit organizations that are committed ... The announcement is made as the global DMD ... Day on Monday, September 7, 2015. ...
(Date:9/4/2015)... -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ... on the development of oral drug delivery systems, announced ... Rodman & Renshaw 17 th Annual Global Investment ... New York City .  Dr. Michael Berelowitz ... on September 9, 2015. Presentation Details: ...
(Date:9/4/2015)... , September 4, 2015 Future ... Allergic Rhinitis drugs - new ... Where is the market for allergic rhinitis drugs ... Visiongain ,s new report shows you potential revenues ... prospects. Our 326 page report provides 273 ...
Breaking Medicine Technology:PTC Therapeutics Announces Five Winners In Its First-ever Global Duchenne Muscular Dystrophy Patient Group Award 2PTC Therapeutics Announces Five Winners In Its First-ever Global Duchenne Muscular Dystrophy Patient Group Award 3PTC Therapeutics Announces Five Winners In Its First-ever Global Duchenne Muscular Dystrophy Patient Group Award 4Oramed to Present at the Rodman & Renshaw Global Investment Conference 2Oramed to Present at the Rodman & Renshaw Global Investment Conference 3Allergic Rhinitis Drugs Market Forecast 2015-2025 2Allergic Rhinitis Drugs Market Forecast 2015-2025 3Allergic Rhinitis Drugs Market Forecast 2015-2025 4Allergic Rhinitis Drugs Market Forecast 2015-2025 5Allergic Rhinitis Drugs Market Forecast 2015-2025 6Allergic Rhinitis Drugs Market Forecast 2015-2025 7
... Promising Clinical Activity in Patients with ... Difficult-to-Treat Cancers -, ... (Nasdaq: SNSS ) presented data from three clinical,trials of ... Foundation Symposium held in New York on November 4-8.,Data previously ...
... Inc.,(Nasdaq: MEDX ) today announced that it ... from its licensing partner, Centocor R&D Inc., for,the ... 95, a fully human antibody,targeting the integrin receptors ... human antibody was generated using Medarex,s,UltiMAb(R) technology. Medarex ...
Cached Medicine Technology:Sunesis Pharmaceuticals Presents Clinical Trial Data of Voreloxin in Patients with Acute Myeloid Leukemia and Ovarian Cancer at the Chemotherapy Foundation Symposium 2Sunesis Pharmaceuticals Presents Clinical Trial Data of Voreloxin in Patients with Acute Myeloid Leukemia and Ovarian Cancer at the Chemotherapy Foundation Symposium 3Sunesis Pharmaceuticals Presents Clinical Trial Data of Voreloxin in Patients with Acute Myeloid Leukemia and Ovarian Cancer at the Chemotherapy Foundation Symposium 4Sunesis Pharmaceuticals Presents Clinical Trial Data of Voreloxin in Patients with Acute Myeloid Leukemia and Ovarian Cancer at the Chemotherapy Foundation Symposium 5Medarex Receives Milestone Payment for Investigational Antibody Targeting Integrin Receptors 2
VACUETTE Trace Element tubes - Ridged (safety screw cap) are designed to test trace elements such as Cu, Zn, Pb, etc....
Inquire...
VACUETTE paediatric tubes have decreased sample volumes and are ideal for small childrens' veins and geriatric patients....
Inquire...
Medicine Products: